Chemical Structure (Inavolisib 01)
Itovebi Tablet, Film Coated
Product Images NDC 50242-079
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Itovebi (NDC 50242-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Inavolisib 02)
Principal Display Panel (9 mg Tablet Bottle Carton)
This text provides information about Itovebi™ (inavolisib) Tablets in 9 mg dosage. It instructs to swallow the tablets whole and not to chew, crush, or split them. The package contains 28 tablets by Genentech.*
Principal Display Panel (3 mg Tablet Bottle Carton)
This is a medication with the name Itovebi™, also known as inavolisib, presented in tablet form. The instructions indicate that the tablets should be swallowed whole and should not be chewed, crushed, or split. The package contains 28 tablets and is manufactured by Genentech.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
